Josias Pontes

Insider Reports History

Entity
Individual
Location
C/O Sigilon Therapeutics, Inc., 100 Binney Street, Suite 600, Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Josias Pontes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 0 $14.92 Aug 11, 2023 Direct
Sigilon Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 0 $6.64 Aug 11, 2023 Direct

Insider Reports Filed by Josias Pontes

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 2 -$8.08K 4 Aug 11, 2023 CHIEF FINANCIAL OFFICER
SGTX Sigilon Therapeutics, Inc. Jul 21, 2023 2 $27.8K 4 Jul 24, 2023 CHIEF FINANCIAL OFFICER
SGTX Sigilon Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 1, 2023 CHIEF FINANCIAL OFFICER
SGTX Sigilon Therapeutics, Inc. Feb 18, 2022 1 $88.8K 4 Feb 22, 2022 ACTING CHIEF FINANCIAL OFFICE
SGTX Sigilon Therapeutics, Inc. Jan 3, 2022 1 $197K 4 Jan 4, 2022 VP, HEAD OF FINANCE
SGTX Sigilon Therapeutics, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 VP, HEAD OF FINANCE
SGTX Sigilon Therapeutics, Inc. Jun 14, 2021 0 $0 3 Jun 21, 2021 VP, Head of Finance